Global HealthPharmaceutical Regulations in Japan

JPMA Position Statements

JPMA is committed to contributing to the better health of patients worldwide through the promotion of drug discovery, research and development. In support of such research and to ensure that the resulting medicines safely reach the patients that need them, the JPMA has shared statements in the following areas:

Recommendations of the JPMA on the G7 Health Ministers' Meeting (Outline):

JPMA submitted “Recommendations of the JPMA on the G7 Health Ministers' Meeting” to the Minister of Health, Labour and Welfare. Please click here to learn more about JPMA' recommendations.
Please click here to read more.

JPMA's Activities for Access to Medicines in Developing Countries:

The United Nations High-Level Panel on Access to Medicines issued a report on September 14, 2016. JPMA recognizes that there are multi-layered challenges in addressing global access to medicines. It requires a solution with a holistic approach.
Please click here to read more.

JPMA recommendations for G7 Health Minister's Meeting:

JPMA submitted “recommendations for G7 Health Minister's Meeting” to the Minister of Health, Labour and Welfare on July 26, 2016. Please click here to learn more about JPMA' proposals.

G7 Ise-Shima Summit:

JPMA submitted “Requests for the Health Agendas at the G7 Ise-Shima Summit” to the Minister of Health, Labour and Welfare in April 2016. Please click here to learn more about JPMA' proposals.

Counterfeit Medicines:

We work to protect patients from the dangers of counterfeit medicines that are presented as genuine and approved products. Please click here to learn more about JPMA' proposals.

Intellectual Property Rights:

We promote understanding of the important role of intellectual property rights in enabling drug discovery, research and development for new medicines while also creating access to such medicines. Please click here to learn more about JPMA' proposals.

Universal Health Coverage:

We are engaged in the ongoing discussion regarding the Post-2015 United Nations sustainable development goals and sees universal health coverage as a key contributor to the wealth and economic productivity of countries. Please click here to learn more about JPMA' proposals.

Page Top

  • Office of Pharmaceutical Industry Research(OPIR)
  • Global Health
  • Stop AMR
  • APAC